Neyssa Marina
About Neyssa Marina
Neyssa Marina serves as the Senior Medical Director at Arcus Biosciences, bringing extensive experience in oncology and clinical trials. She has held various academic and leadership positions, including roles at Stanford Children's Health and St. Jude Children's Research Hospital.
Current Role at Arcus Biosciences
Neyssa Marina serves as the Senior Medical Director at Arcus Biosciences, a role she has held since 2023. In this position, she works in Hayward, California, focusing on the design and execution of clinical trials. Her responsibilities include collaborating with cross-functional teams to ensure the successful reporting of early-phase clinical trials.
Previous Experience at St. Jude Children's Research Hospital
Neyssa Marina has a significant history with St. Jude Children's Research Hospital. She worked there as a Post-doctoral fellow from 1986 to 1989 for three years. Additionally, she served as an Assistant Member from 1989 to 1995 for six years and briefly as an Associate Member in 1995. Her time at St. Jude contributed to her expertise in pediatric oncology.
Academic Background and Education
Neyssa Marina holds a Bachelor of Science in Chemistry from the University of Puerto Rico-Mayaguez, which she completed from 1975 to 1979. She earned her MD from the University of Puerto Rico School of Medicine from 1979 to 1983. Furthering her education, she obtained a Master's degree in Epidemiology from Stanford University from 2009 to 2011.
Tenure at Stanford University School of Medicine
Neyssa Marina has had a long-standing association with Stanford University School of Medicine. She served as a Professor from 2001 to 2017 for 16 years and as an Associate Professor from 1995 to 2001 for six years. Since 2017, she has held the title of Professor Emeritus, contributing to the academic community in Palo Alto, California.
Experience in the Biotechnology Sector
Neyssa Marina transitioned from pediatric oncology to the biotechnology sector to enhance cancer care through clinical trials. She worked as Executive Medical Director at Synthorx Inc for one year in 2019-2020 and as Senior Medical Director at Sanofi from 2021 to 2023. Her focus remains on the design, development, and analysis of clinical trials specifically for oncology patients.